|
|
| MRD / Regn No. |
: THBC\23-24\03660 |
Date |
: 18/06/2026 |
| Patient Name |
: Hemlata Sanjay Tiwari |
Age & Gender |
: 54 Yrs. / Female |
| Contact No. |
: 971552035178 |
UHID |
: |
| Ht / Wt / BMI |
: 162.5 / 70.65 / 26.76 |
BP S / BP D |
: 138 / 83 |
| Allergies |
: NONE |
Referred By |
: |
| |
|
|
Subjective |
: |
PRIMARY HYPOTHYROIDISM SINCE 2008,HYPERTHYROIDISM APRIL 2024 TO FEB 2026,OFF NMZ - REPORTS ARE NORMAL,STARTING SAROGLITAZAR - RAISED LFT / FATTY LIVER |
|
Objective |
: |
MAY 26- FBS- 114/HBA1C- 7.2,TC- 155/TG- 169/LDL-88/HDL- 50,CREAT-0.75,ALT- 57/AST- 39,FT3- 3.42/FT4- 1.42/TSH- 1.43,HB- 11.2 |
|
Plan |
: |
TSH RECEPTOR ANTIBODY TO BE CHECKED - IF NEGATIVE - - THEN STOP NMZ |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
DAPATURN 10 MG |
ORAL |
1-0-0 |
ABF
|
4 MTHS |
|
|
2 |
TELISTA TRIO CL (40/10/6.25) |
ORAL |
1-0-0 |
ABF
|
4 MTHS |
|
|
3 |
PROLOMET T 25/40 MG |
ORAL |
0-0-1 |
AD
|
4 MTHS |
|
|
4 |
ROSUVASTATIN 10 MG
ROSEDAY 10 MG |
ORAL |
0-0-1 |
AD
|
4 MTHS |
|
|
5 |
LIPAGLYN / VORAXAR / BILYPSA 4 |
ORAL |
0-0-1 |
AD
|
4 MTHS |
|
|
6 |
SHELCAL XT |
ORAL |
0-1-0 |
ALT DAY
|
4 MTHS |
|
|
7 |
UPRISE D3 60K |
ORAL |
1/ MTH |
ANYTIME OF THE DAY
|
TO CONTINUE |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 18/Oct/2026 |
| Tests Suggested For Next Visit |
: HBA1C / FT3 / FT4 /TSH / FBS / PPBS / LFT > 4 MTHS |
| |
|
| |
|
|
